Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease

Wild, 2004, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care, 27, 1047, 10.2337/diacare.27.5.1047

Kelly, 2008, Global burden of obesity in 2005 and projections to 2030, Int. J. Obes., 32, 1431, 10.1038/ijo.2008.102

Whitmer, 2008, Central obesity and increased risk of dementia more than three decades later, Neurology, 71, 1057, 10.1212/01.wnl.0000306313.89165.ef

Jagust, 2005, Central obesity and the aging brain, Arch. Neurol., 62, 1545, 10.1001/archneur.62.10.1545

Whitmer, 2005, Obesity in middle age and future risk of dementia: a 27year longitudinal population based study, BMJ, 330, 1360, 10.1136/bmj.38446.466238.E0

Hassing, 2009, Overweight in midlife and risk of dementia: a 40-year follow-up study, Int. J. Obes., 33, 893, 10.1038/ijo.2009.104

Hassing, 2010, Overweight in midlife is related to lower cognitive function 30years later: a prospective study with longitudinal assessments, Dement. Geriatr. Cogn. Disord., 29, 543, 10.1159/000314874

Anstey, 2011, Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies, Obes. Rev., 12, e426, 10.1111/j.1467-789X.2010.00825.x

Fitzpatrick, 2009, Midlife and late-life obesity and the risk of dementia: cardiovascular health study, Arch. Neurol., 66, 336, 10.1001/archneurol.2008.582

Xu, 2011, Midlife overweight and obesity increase late-life dementia risk: a population-based twin study, Neurology, 76, 1568, 10.1212/WNL.0b013e3182190d09

Wotton, 2014, Age at obesity and association with subsequent dementia: record linkage study, Postgrad. Med. J., 90, 547, 10.1136/postgradmedj-2014-132571

Nepal, 2014, Rising midlife obesity will worsen future prevalence of dementia, PLoS One, 9, 10.1371/journal.pone.0099305

Qizilbash, 2015, BMI and risk of dementia in two million people over two decades: a retrospective cohort study, Lancet Diabetes Endocrinol., 3, 431, 10.1016/S2213-8587(15)00033-9

Lee, 2013, Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes, Diabetes, 62, 194, 10.2337/db12-0420

Snodgrass, 2013, Inflammasome-mediated secretion of IL-1beta in human monocytes through TLR2 activation; modulation by dietary fatty acids, J. Immunol., 191, 4337, 10.4049/jimmunol.1300298

Purdon, 1997, No evidence for direct incorporation of esterified palmitic acid from plasma into brain lipids of awake adult rat, J. Lipid Res., 38, 526, 10.1016/S0022-2275(20)37260-6

Karmi, 2010, Increased brain fatty acid uptake in metabolic syndrome, Diabetes, 59, 2171, 10.2337/db09-0138

Cole, 2010, Dietary fatty acids and the aging brain, Nutr. Rev., 68, S102, 10.1111/j.1753-4887.2010.00345.x

Gupta, 2012, Saturated long-chain fatty acids activate inflammatory signaling in astrocytes, J. Neurochem., 120, 1060, 10.1111/j.1471-4159.2012.07660.x

Milanski, 2009, Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity, J. Neurosci., 29, 359, 10.1523/JNEUROSCI.2760-08.2009

Takalo, 2014, High-fat diet increases tau expression in the brain of T2DM and AD mice independently of peripheral metabolic status, J. Nutr. Biochem., 25, 634, 10.1016/j.jnutbio.2014.02.003

Wilson, 1997, Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease, Am. J. Pathol., 150, 2181

Cukierman-Yaffe, 2009, Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial, Diabetes Care, 32, 221, 10.2337/dc08-1153

Ohara, 2011, Glucose tolerance status and risk of dementia in the community: the Hisayama study, Neurology, 77, 1126, 10.1212/WNL.0b013e31822f0435

Ding, 2010, Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study, Diabetes, 59, 2883, 10.2337/db10-0752

Crane, 2013, Glucose levels and risk of dementia, N. Engl. J. Med., 369, 540, 10.1056/NEJMoa1215740

Spauwen, 2013, Effects of type 2 diabetes on 12-year cognitive change: results from the Maastricht Aging Study, Diabetes Care, 36, 1554, 10.2337/dc12-0746

Cukierman, 2005, Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies, Diabetologia, 48, 2460, 10.1007/s00125-005-0023-4

Yaffe, 2006, Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women, J. Nutr. Health Aging, 10, 293

Sommerfield, 2004, Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes, Diabetes Care, 27, 2335, 10.2337/diacare.27.10.2335

Ravona-Springer, 2012, Changes in glycemic control are associated with changes in cognition in non-diabetic elderly, J. Alzheimers Dis., 30, 299, 10.3233/JAD-2012-120106

Ravona-Springer, 2014, Trajectories in glycemic control over time are associated with cognitive performance in elderly subjects with type 2 diabetes, PLoS One, 9, 10.1371/journal.pone.0097384

Kirkman, 2012, Diabetes in older adults: a consensus report, J. Am. Geriatr. Soc., 60, 2342, 10.1111/jgs.12035

Baker, 2011, Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes, Arch. Neurol., 68, 51, 10.1001/archneurol.2010.225

Strachan, 2011, Cognitive function, dementia and type 2 diabetes mellitus in the elderly, Nat. Rev. Endocrinol., 7, 108, 10.1038/nrendo.2010.228

Wang, 2014, Epigenetic mechanisms linking diabetes and synaptic impairments, Diabetes, 63, 645, 10.2337/db13-1063

Qiu, 2006, Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis, Neurobiol. Aging, 27, 190, 10.1016/j.neurobiolaging.2005.01.004

Haque, 2014, Insulin-degrading enzyme: a link between Alzheimer's and type 2 diabetes mellitus, CNS Neurol. Disord. Drug Targets, 13, 259, 10.2174/18715273113126660139

Akter, 2011, Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?, Br. J. Clin. Pharmacol., 71, 365, 10.1111/j.1365-2125.2010.03830.x

Kroner, 2009, The relationship between Alzheimer's disease and diabetes: type 3 diabetes?, Altern. Med. Rev., 14, 373

Ramos-Rodriguez, 2014, Central proliferation and neurogenesis is impaired in type 2 diabetes and prediabetes animal models, PLoS One, 9, 10.1371/journal.pone.0089229

Gage, 2000, Mammalian neural stem cells, Science, 287, 1433, 10.1126/science.287.5457.1433

Lang, 2009, Impaired neurogenesis in adult type-2 diabetic rats, Brain Res., 1258, 25, 10.1016/j.brainres.2008.12.026

Beauquis, 2008, Prominently decreased hippocampal neurogenesis in a spontaneous model of type 1 diabetes, the nonobese diabetic mouse, Exp. Neurol., 210, 359, 10.1016/j.expneurol.2007.11.009

Guo, 2010, Impaired neural stem/progenitor cell proliferation in streptozotocin-induced and spontaneous diabetic mice, Neurosci. Res., 68, 329, 10.1016/j.neures.2010.08.012

Li, 2012, IKKbeta/NF-kappaB disrupts adult hypothalamic neural stem cells to mediate a neurodegenerative mechanism of dietary obesity and pre-diabetes, Nat. Cell Biol., 14, 999, 10.1038/ncb2562

Qin, 2015, Regulation of cAMP response element binding protein during neuroglial interactions, J. Neurochem.

Goh, 2008, Clinical review: the role of advanced glycation end products in progression and complications of diabetes, J. Clin. Endocrinol. Metab., 93, 1143, 10.1210/jc.2007-1817

Srikanth, 2011, Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease, Neurobiol. Aging, 32, 763, 10.1016/j.neurobiolaging.2009.04.016

Toth, 2007, RAGE, diabetes, and the nervous system, Curr. Mol. Med., 7, 766, 10.2174/156652407783220705

Guglielmotto, 2012, AGEs/RAGE complex upregulates BACE1 via NF-kappaB pathway activation, Neurobiol. Aging, 33, e113

Kojro, 2009, Regulated proteolysis of RAGE and AbetaPP as possible link between type 2 diabetes mellitus and Alzheimer's disease, J. Alzheimers Dis., 16, 865, 10.3233/JAD-2009-0998

Liu, 2009, Upregulation of RAGE at the blood–brain barrier in streptozotocin-induced diabetic mice, Synapse, 63, 636, 10.1002/syn.20644

Cai, 2014, Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans, Proc. Natl. Acad. Sci. U. S. A., 111, 4940, 10.1073/pnas.1316013111

Beeri, 2011, Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals, Mech. Ageing Dev., 132, 583, 10.1016/j.mad.2011.10.007

Byun, 2012, Induction of neuronal death by microglial AGE-albumin: implications for Alzheimer's disease, PLoS One, 7, 10.1371/journal.pone.0037917

Yan, 1996, RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease, Nature, 382, 685, 10.1038/382685a0

Lue, 2001, Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism, Exp. Neurol., 171, 29, 10.1006/exnr.2001.7732

Choi, 2014, Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease, Exp. Mol. Med., 46, 10.1038/emm.2013.147

Sasaki, 2001, Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease, Brain Res., 888, 256, 10.1016/S0006-8993(00)03075-4

Miller, 2008, Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease, Brain Res., 1230, 273, 10.1016/j.brainres.2008.06.124

Wang, 2014, Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs/RAGE/NF-kappaB pathway, Int. J. Neurosci., 124, 601, 10.3109/00207454.2013.866110

Fang, 2010, RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease, FASEB J., 24, 1043, 10.1096/fj.09-139634

Arancio, 2004, RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice, EMBO J., 23, 4096, 10.1038/sj.emboj.7600415

Deane, 2012, A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease, J. Clin. Invest., 122, 1377, 10.1172/JCI58642

Galasko, 2014, Clinical trial of an inhibitor of RAGE-Abeta interactions in Alzheimer disease, Neurology, 82, 1536, 10.1212/WNL.0000000000000364

Walker, 2015, Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease, Expert Opin. Investig. Drugs, 24, 393, 10.1517/13543784.2015.1001490

Selvin, 2013, sRAGE and risk of diabetes, cardiovascular disease, and death, Diabetes, 62, 2116, 10.2337/db12-1528

Liang, 2013, Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer's disease, J. Clin. Neurosci., 20, 357, 10.1016/j.jocn.2012.06.005

Cai, 2012, Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1, Proc. Natl. Acad. Sci. U. S. A., 109, 15888, 10.1073/pnas.1205847109

Poulsen, 2013, Advanced glycation endproducts in food and their effects on health, Food Chem. Toxicol., 60, 10, 10.1016/j.fct.2013.06.052

West, 2014, Dietary advanced glycation end products are associated with decline in memory in young elderly, Mech. Ageing Dev., 140, 10, 10.1016/j.mad.2014.07.001

Carvalho, 2012, Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities, Diabetes, 61, 1234, 10.2337/db11-1186

Gurung, 2015, Mitochondria: diversity in the regulation of the NLRP3 inflammasome, Trends Mol. Med., 21, 193, 10.1016/j.molmed.2014.11.008

Sorbara, 2011, Mitochondrial ROS fuel the inflammasome, Cell Res., 21, 558, 10.1038/cr.2011.20

West, 2015, Mitochondrial DNA stress primes the antiviral innate immune response, Nature, 10.1038/nature14156

Lamkanfi, 2014, Mechanisms and functions of inflammasomes, Cell, 157, 1013, 10.1016/j.cell.2014.04.007

Laudisi, 2013, Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1beta release, J. Immunol., 191, 1006, 10.4049/jimmunol.1300489

Kaushal, 2015, Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation, Cell Death Differ., 10.1038/cdd.2015.16

Shimada, 2012, Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis, Immunity, 36, 401, 10.1016/j.immuni.2012.01.009

Motori, 2013, Inflammation-induced alteration of astrocyte mitochondrial dynamics requires autophagy for mitochondrial network maintenance, Cell Metab., 18, 844, 10.1016/j.cmet.2013.11.005

Poitout, 2008, Glucolipotoxicity: fuel excess and beta-cell dysfunction, Endocr. Rev., 29, 351, 10.1210/er.2007-0023

Wen, 2011, Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling, Nat. Immunol., 12, 408, 10.1038/ni.2022

Burm, 2015, Inflammasome-induced IL-1beta secretion in microglia is characterized by delayed kinetics and is only partially dependent on inflammatory caspases, J. Neurosci., 35, 678, 10.1523/JNEUROSCI.2510-14.2015

Cai, 2012, One step from prediabetes to diabetes: hypothalamic inflammation?, Endocrinology, 153, 1010, 10.1210/en.2011-2183

Rubartelli, 2014, DAMP-mediated activation of NLRP3-inflammasome in brain sterile inflammation: the fine line between healing and neurodegeneration, Front. Immunol., 5, 99, 10.3389/fimmu.2014.00099

Jabaut, 2013, Mitochondria-targeted drugs enhance Nlrp3 inflammasome-dependent IL-1beta secretion in association with alterations in cellular redox and energy status, Free Radic. Biol. Med., 60, 233, 10.1016/j.freeradbiomed.2013.01.025

Sokolowski, 2014, Fractalkine is a “find-me” signal released by neurons undergoing ethanol-induced apoptosis, Front. Cell. Neurosci., 8, 360, 10.3389/fncel.2014.00360

Min, 2013, Sirtuins in neurodegenerative diseases: an update on potential mechanisms, Front. Aging Neurosci., 5, 53, 10.3389/fnagi.2013.00053

Ng, 2015, SIRT1 in the brain-connections with aging-associated disorders and lifespan, Front. Cell. Neurosci., 9, 64, 10.3389/fncel.2015.00064

Gan, 2008, Paths of convergence: sirtuins in aging and neurodegeneration, Neuron, 58, 10, 10.1016/j.neuron.2008.03.015

Chen, 2005, SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling, J. Biol. Chem., 280, 40364, 10.1074/jbc.M509329200

Yoshizaki, 2009, SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes, Mol. Cell. Biol., 29, 1363, 10.1128/MCB.00705-08

Glass, 2010, Mechanisms underlying inflammation in neurodegeneration, Cell, 140, 918, 10.1016/j.cell.2010.02.016

Wright, 2013, Neuroinflammation and neuronal loss precede Abeta plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease, PLoS One, 8, 10.1371/journal.pone.0059586

Hanzel, 2014, Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease, Neurobiol. Aging, 35, 2249, 10.1016/j.neurobiolaging.2014.03.026

Di Filippo, 2013, Effects of central and peripheral inflammation on hippocampal synaptic plasticity, Neurobiol. Dis., 52, 229, 10.1016/j.nbd.2012.12.009

Franceschi, 2007, Inflammaging as a major characteristic of old people: can it be prevented or cured?, Nutr. Rev., 65, S173, 10.1301/nr.2007.dec.S173-S176

Shoelson, 2006, Inflammation and insulin resistance, J. Clin. Invest., 116, 1793, 10.1172/JCI29069

Skelly, 2013, A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1beta, [corrected] TNF-alpha and IL-6 challenges in C57BL/6 mice, PLoS One, 8, 10.1371/annotation/90c76048-2edd-4315-8404-4d9d8cbd411e

Krstic, 2012, Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice, J. Neuroinflammation, 9, 151, 10.1186/1742-2094-9-151

Swardfager, 2010, A meta-analysis of cytokines in Alzheimer's disease, Biol. Psychiatry, 68, 930, 10.1016/j.biopsych.2010.06.012

Zhang, 2013, Systemic immune system alterations in early stages of Alzheimer's disease, J. Neuroimmunol., 256, 38, 10.1016/j.jneuroim.2013.01.002

Bermejo, 2008, Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease, Immunol. Lett., 117, 198, 10.1016/j.imlet.2008.02.002

van Himbergen, 2012, Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and Alzheimer disease: results from the Framingham Heart Study, Arch. Neurol., 69, 594, 10.1001/archneurol.2011.670

Koyama, 2013, The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis, J. Gerontol. Ser. A Biol. Sci. Med. Sci., 68, 433, 10.1093/gerona/gls187

Tan, 2007, Inflammatory markers and the risk of Alzheimer disease: the Framingham Study, Neurology, 68, 1902, 10.1212/01.wnl.0000263217.36439.da

Magaki, 2007, Increased production of inflammatory cytokines in mild cognitive impairment, Exp. Gerontol., 42, 233, 10.1016/j.exger.2006.09.015

Peng, 2013, Role of peripheral inflammatory markers in postoperative cognitive dysfunction (POCD): a meta-analysis, PLoS One, 8

Banks, 1991, Blood to brain transport of interleukin links the immune and central nervous systems, Life Sci., 48, PL117, 10.1016/0024-3205(91)90385-O

Banks, 1995, Passage of cytokines across the blood–brain barrier, Neuroimmunomodulation, 2, 241, 10.1159/000097202

Gutierrez, 1993, Murine tumor necrosis factor alpha is transported from blood to brain in the mouse, J. Neuroimmunol., 47, 169, 10.1016/0165-5728(93)90027-V

Dilger, 2008, Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system, J. Leukoc. Biol., 84, 932, 10.1189/jlb.0208108

Thomson, 2014, Peripheral inflammation is associated with remote global gene expression changes in the brain, J. Neuroinflammation, 11, 73, 10.1186/1742-2094-11-73

Haseloff, 2015, Transmembrane proteins of the tight junctions at the blood–brain barrier: structural and functional aspects, Semin. Cell Dev. Biol., 38, 16, 10.1016/j.semcdb.2014.11.004

Montagne, 2015, Blood–brain barrier breakdown in the aging human hippocampus, Neuron, 85, 296, 10.1016/j.neuron.2014.12.032

Freeman, 2012, Vascular changes in rat hippocampus following a high saturated fat and cholesterol diet, J. Cereb. Blood Flow Metab., 32, 643, 10.1038/jcbfm.2011.168

Davidson, 2012, The effects of a high-energy diet on hippocampal-dependent discrimination performance and blood–brain barrier integrity differ for diet-induced obese and diet-resistant rats, Physiol. Behav., 107, 26, 10.1016/j.physbeh.2012.05.015

Tucsek, 2014, Obesity in aging exacerbates blood–brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: effects on expression of genes involved in beta-amyloid generation and Alzheimer's disease, J. Gerontol. Ser. A Biol. Sci. Med. Sci., 69, 1212, 10.1093/gerona/glt177

Pallebage-Gamarallage, 2012, Restoration of dietary-fat induced blood–brain barrier dysfunction by anti-inflammatory lipid-modulating agents, Lipids Health Dis., 11, 117, 10.1186/1476-511X-11-117

Mortuza, 2013, High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway, PLoS One, 8, 10.1371/journal.pone.0054514

Allen, 2009, Antioxidants attenuate hyperglycaemia-mediated brain endothelial cell dysfunction and blood–brain barrier hyperpermeability, Diabetes Obes. Metab., 11, 480, 10.1111/j.1463-1326.2008.00987.x

Navaratna, 2013, Cerebrovascular degradation of TRKB by MMP9 in the diabetic brain, J. Clin. Invest., 123, 3373, 10.1172/JCI65767

Liu, 2015, SIRT3 protects endothelial cells from high glucose-induced cytotoxicity, Int. J. Clin. Exp. Pathol., 8, 353

Ouyang, 2014, Diet-induced obesity suppresses expression of many proteins at the blood–brain barrier, J. Cereb. Blood Flow Metab., 34, 43, 10.1038/jcbfm.2013.166

Ott, 1937, Diabetes mellitus and the risk of dementia. The Rotterdam study, Neurology, 53

Huang, 2014, Diabetes mellitus and the risk of Alzheimer's disease: a nationwide population-based study, PLoS One, 9

Ho, 2010, Obesity is linked with lower brain volume in 700AD and MCI patients, Neurobiol. Aging, 31, 1326, 10.1016/j.neurobiolaging.2010.04.006

Profenno, 2010, Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders, Biol. Psychiatry, 67, 505, 10.1016/j.biopsych.2009.02.013

Wang, 2012, Risk of Alzheimer's disease in relation to diabetes: a population-based cohort study, Neuroepidemiology, 38, 237, 10.1159/000337428

Chuang, 2015, Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation, Mol. Psychiatry

Ho, 2004, Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease, FASEB J., 18, 902, 10.1096/fj.03-0978fje

Jolivalt, 2010, Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice, Exp. Neurol., 223, 422, 10.1016/j.expneurol.2009.11.005

Takeda, 2010, Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes, Proc. Natl. Acad. Sci. U. S. A., 107, 7036, 10.1073/pnas.1000645107

Kohjima, 2010, Increased food intake leads to obesity and insulin resistance in the tg2576 Alzheimer's disease mouse model, Endocrinology, 151, 1532, 10.1210/en.2009-1196

Fu, 2013, Amylin receptor: a common pathophysiological target in Alzheimer's disease and diabetes mellitus, Front. Aging Neurosci., 5, 42, 10.3389/fnagi.2013.00042

Ioacara, 2011, Improvements in life expectancy in adult type 2 diabetes patients in the last six decades, Diabetes Res. Clin. Pract., 92, 400, 10.1016/j.diabres.2011.03.022

Han, 2010, Linking type 2 diabetes and Alzheimer's disease, Proc. Natl. Acad. Sci. U. S. A., 107, 6557, 10.1073/pnas.1002555107